These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37535323)

  • 1. Alignment of Ending the HIV Epidemic Priority Jurisdictions With Availability of HIV Service Organizations: An Ecological Study.
    Webster JL; Rafalko N; Thorpe LE; Duncan DT; Gracely EJ; Goldstein ND
    AIDS Educ Prev; 2023 Aug; 35(4):320-331. PubMed ID: 37535323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.
    Sullivan PS; Mouhanna F; Mera R; Pembleton E; Castel AD; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Siegler AJ
    Ann Epidemiol; 2020 Apr; 44():16-30. PubMed ID: 32088073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Availability of Sexually Transmitted Disease and HIV Clinical Services: Ending the HIV Epidemic Versus Non-Ending the HIV Epidemic Jurisdictions, 2018.
    Leichliter JS; Cuffe KM; Kelley KR; Gift TL
    Sex Transm Dis; 2022 Jan; 49(1):e13-e16. PubMed ID: 34030153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. America's HIV Epidemic Analysis Dashboard: Protocol for a Data Resource to Support Ending the HIV Epidemic in the United States.
    Sullivan PS; Woodyatt CR; Kouzouian O; Parrish KJ; Taussig J; Conlan C; Phillips H
    JMIR Public Health Surveill; 2022 Feb; 8(2):e33522. PubMed ID: 35142639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the sensitivity of jurisdictional heterogeneity and jurisdictional mixing in national level HIV prevention analyses: context of the U.S. ending the HIV epidemic plan.
    Tatapudi H; Gopalappa C
    BMC Med Res Methodol; 2022 Nov; 22(1):304. PubMed ID: 36435750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ending the HIV Epidemic: New York's Quest to Become the First State to Reduce HIV Prevalence.
    Morne JE; Tesoriero JM; Martin EG; Birkhead GS; Holtgrave DR; Hagos K; Zucker H
    Public Health Rep; 2020; 135(1_suppl):65S-74S. PubMed ID: 32735198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017.
    Finlayson T; Cha S; Xia M; Trujillo L; Denson D; Prejean J; Kanny D; Wejnert C;
    MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(27):597-603. PubMed ID: 31298662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U.S. Black Women and Human Immunodeficiency Virus Preexposure Prophylaxis Implementation.
    Hoover KW; Kourtis AP; Smith DK
    Obstet Gynecol; 2022 Jul; 140(1):106-109. PubMed ID: 35849466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Community Health Worker Approach for Ending the HIV Epidemic.
    Hammack AY; Bickham JN; Gilliard I; Robinson WT
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S26-S31. PubMed ID: 34686287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of the Portfolio of NIH-Funded HIV Implementation Research Projects to Inform Ending the HIV Epidemic Strategies.
    Queiroz A; Mongrella M; Keiser B; Li DH; Benbow N; Mustanski B
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S23-S31. PubMed ID: 35703752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging Medicaid to Enhance Preexposure Prophylaxis Implementation Efforts and Ending the HIV Epidemic.
    Chan PA; Seiler N; Chu CT
    Am J Public Health; 2020 Jan; 110(1):65-66. PubMed ID: 31800270
    [No Abstract]   [Full Text] [Related]  

  • 12. Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals.
    Jenness SM; Johnson JA; Hoover KW; Smith DK; Delaney KP
    AIDS; 2020 Nov; 34(14):2103-2113. PubMed ID: 32910062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.
    Palummieri A; De Carli G; Rosenthal É; Cacoub P; Mussini C; Puro V;
    BMC Infect Dis; 2017 Nov; 17(1):734. PubMed ID: 29179700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pre-exposure and post-exposure prophylaxes prevention programme on HIV burden and services in a low-resource setting: a simulation modelling approach.
    Adeoti AO; Demir E; Adeyemi S; Yakutcan U; Kengne AP; Kayode G; Aliyu A; Idika N; Isichei C
    Pan Afr Med J; 2021; 40():163. PubMed ID: 34970405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulating the End of AIDS in New York: Using Participatory Dynamic Modeling to Improve Implementation of the Ending the Epidemic Initiative.
    Martin EG; MacDonald RH; Gordon DE; Swain CA; O'Donnell T; Helmeset J; Dwicaksono A; Tesoriero JM
    Public Health Rep; 2020; 135(1_suppl):158S-171S. PubMed ID: 32735199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and Initial Management of HIV Infection.
    Feinberg J; Keeshin S
    Ann Intern Med; 2022 Jun; 175(6):ITC81-ITC96. PubMed ID: 35696682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.
    Shaw G; Schaefer R; Schmidt HA; Madden A; Chang J; Mozalevskis A; Msimanga-Radebe B; Mangadan Konath N; Verster A; Baggaley R; Rodolph M; Macdonald V
    Harm Reduct J; 2023 Feb; 20(1):16. PubMed ID: 36782321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis - United States, 2013-2018.
    Harris NS; Johnson AS; Huang YA; Kern D; Fulton P; Smith DK; Valleroy LA; Hall HI
    MMWR Morb Mortal Wkly Rep; 2019 Dec; 68(48):1117-1123. PubMed ID: 31805031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness, knowledge, and attitudes related to HIV pre-exposure prophylaxis and other prevention strategies among physicians from Brazil and Mexico: cross-sectional web-based survey.
    Vega-Ramirez H; Torres TS; Guillen-Diaz C; Pimenta C; Diaz-Sosa D; Konda KA; da Cunha ARC; Robles-Garcia R; Benedetti M; Hoagland B; Bezerra DRB; Caceres CF; Grinsztejn B; Veloso VG;
    BMC Health Serv Res; 2022 Apr; 22(1):532. PubMed ID: 35459177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ending the HIV epidemic with the Help of biomedical Prevention Interventions.
    Toynton P; O'Brien KA
    MD Advis; 2017; 10(2):7-14. PubMed ID: 28586567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.